Pathogen-specific IgG antibody levels in immunodeficient patients receiving immunoglobulin replacement do not provide additional benefit to therapeutic management over total serum IgG

J Allergy Clin Immunol. 2011 Jun;127(6):1410-1. doi: 10.1016/j.jaci.2011.01.035. Epub 2011 Mar 3.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Bacterial / blood
  • Antibody Specificity
  • Bacterial Infections / etiology
  • Bacterial Infections / immunology
  • Clostridium tetani / immunology
  • Haemophilus influenzae type b / immunology
  • Humans
  • Immunoglobulin G / blood*
  • Immunoglobulins, Intravenous / therapeutic use*
  • Immunologic Deficiency Syndromes / complications
  • Immunologic Deficiency Syndromes / immunology*
  • Immunologic Deficiency Syndromes / therapy*
  • Streptococcus pneumoniae / immunology

Substances

  • Antibodies, Bacterial
  • Immunoglobulin G
  • Immunoglobulins, Intravenous